Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/keab896 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Membranoproliferative glomerulonephritis (MPGN) has previously been used as an umbrella term to describe a spectrum of hypocomplementemic glomerular diseases, which are rare causes of end stage kidney disease (ESKD). We present a 22-year-old man with a well-established medical history who had been complaining of 4 days of frothy dark urine, bilateral lower limb swelling, and puffiness on his face. For a month before his presentation, he had many bilateral skin lesions on his lower limbs that were leaking pus.
View Article and Find Full Text PDFImmune-Complex Mediated Mesangial Proliferative Glomerulonephritis with Full-House Pattern Observed During Treatment of Immune Thrombocytopenic Purpura.
Clin Med Insights Case Rep
December 2024
Department of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Japan.
This study reports a rare case of immune-complex mediated mesangial proliferative glomerulonephritis (ICGN) with a full-house pattern in a 56-year-old Japanese man, observed during the treatment of immune thrombocytopenic purpura (ITP). Because of persistent complement deficiency and worsening of kidney function, he was treated with prednisolone, and his urinary findings improved markedly. However, as the complement titers were still low, mycophenolate mofetil was also prescribed, which normalized complement levels.
View Article and Find Full Text PDFArticle Synopsis
- Antinuclear antibody-negative lupus nephritis is rare, and some patients may develop antibodies later, indicating underlying immune issues.
- A case study of a 25-year-old woman with lupus symptoms but negative ANA tests emphasizes the need for a holistic approach in diagnosing lupus nephritis, rather than relying solely on serological tests.
- Early intervention with immunosuppressive treatment led to significant improvement, highlighting the importance of swift management in potentially life-saving situations for patients with suspected lupus nephritis.
Key Clinical Message: Non-lupus full house nephropathy is a rare entity that is still poorly understood. It can complicate post-transplant kidneys and result in a de novo process. Treatment is difficult but can be possibly achieved with optimization of immune suppression.
View Article and Find Full Text PDFNonlupus Full House Nephropathy: A Systematic Review.
Clin J Am Soc Nephrol
June 2024
Department of Pathology and Medical Biology, University Medical Center, University of Groningen, Groningen, The Netherlands.
Key Points: Nonlupus full house nephropathy is a rare, complex entity: confusion arises by the low-quality evidence and the lack of consensus on nomenclature. This systematic review supports that systemic lupus erythematosus and nonlupus full house nephropathy are distinct clinical entities, with comparable outcomes. The identification of three pathogenetic categories provides further clues for a shared clinical and diagnostic approach to the disease.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!